These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 697377)

  • 41. [Disturbances in the regulation of phospholipid metabolism of the whole liver, mitochondria and microsomes in acute thioacetamide poisoning and the influcence of silymarin].
    Schriewer H; Lohmann J
    Arzneimittelforschung; 1976; 26(1):65-9. PubMed ID: 947181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative pharmacokinetics and anesthetic effects of methohexital, pentobarbital, thiamylal, and thiopental in Greyhound dogs and non-Greyhound, mixed-breed dogs.
    Sams RA; Muir WW; Detra RL; Robinson EP
    Am J Vet Res; 1985 Aug; 46(8):1677-83. PubMed ID: 4037494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of potassium ethylxanthogenate and 2,3-dimercaptopropane sulphonate sodium on the pentobarbital pharmacokinetics and metabolism in male mice.
    Yanev S; Janku I; Stoytchev T; Havlik I; Krebs V
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):21-9. PubMed ID: 7067720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical pharmacology of legalon (review of the literature)].
    Skakun NP; Moseĭchuk IP
    Vrach Delo; 1988 May; (5):5-10. PubMed ID: 3047986
    [No Abstract]   [Full Text] [Related]  

  • 45. Silymarin, an inhibitor of prostaglandin synthetase.
    Fiebrich F; Koch H
    Experientia; 1979 Dec; 35(12):1550-2. PubMed ID: 118049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Aspects of liver damage after experimental administration of some drugs. Preliminary note].
    Martines G; Copponi V; Cagnetta G
    Arch Sci Med (Torino); 1980; 137(3):367-86. PubMed ID: 7235927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of peniobarbital in the cat and comparisons with the rabbit and man.
    Wagner JG; Weidler DJ; Hallmark MR; Black KL; Domino EF
    Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):375-84. PubMed ID: 847291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The pharmacodynamics of hepatic protectors from the lady's-thistle (Silybum marianum)].
    Rumiantseva ZhN
    Vrach Delo; 1991 May; (5):15-9. PubMed ID: 1866906
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug metabolism in hypothermia. Uptake, metabolism and biliary excretion of pentobarbital-2-C14 by the isolated, perfused rat liver in hypothermia and euthermia.
    Kalser SC; Kelly MP; Forbes EB; Randolph MM
    J Pharmacol Exp Ther; 1969 Nov; 170(1):145-52. PubMed ID: 5350998
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of drugs on the mitochondrial fraction isolated from the liver].
    Braga PC; Cagnetta G; Copponi V
    Clin Ter; 1981 Mar; 96(5):493-501. PubMed ID: 7285520
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of silymarin on UDP-glucuronic acid and glucuronidation activity in the rat isolated hepatocytes and liver in relation to D-galactosamine toxicity.
    Chrungoo VJ; Reen RK; Singh K; Singh J
    Indian J Exp Biol; 1997 Mar; 35(3):256-63. PubMed ID: 9332170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
    Müzes G; Deák G; Láng I; Nékám K; Niederland V; Fehér J
    Orv Hetil; 1990 Apr; 131(16):863-6. PubMed ID: 2345633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations in pentobarbital pharmacokinetics in response to parenteral and enteral alimentation in the rat.
    Knodell RG; Spector MH; Brooks DA; Keller FX; Kyner WT
    Gastroenterology; 1980 Dec; 79(6):1211-6. PubMed ID: 6777235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of antacids on the absorption of orally administered pentobarbital in the rat.
    Hurwitz A; Sheehan MB
    J Pharmacol Exp Ther; 1971 Oct; 179(1):124-31. PubMed ID: 5096563
    [No Abstract]   [Full Text] [Related]  

  • 55. [Mechanism of silybin action, IV. Structure-action relationship (author's transl)].
    Sonnenbichler J; Pohl A
    Hoppe Seylers Z Physiol Chem; 1980 Nov; 361(11):1757-61. PubMed ID: 6161072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proceedings: Pharmacokinetics of pentobarbital in humans with special reference to blood cell and plasma protein binding.
    Ehrnebo M
    Acta Pharm Suec; 1974 Dec; 11(6):655-6. PubMed ID: 1136806
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pharmacologic properties of silybin and silymarin].
    Lecomte J
    Rev Med Liege; 1975 Feb; 30(4):110-4. PubMed ID: 1224091
    [No Abstract]   [Full Text] [Related]  

  • 58. Silymarin, an inhibitor of lipoxygenase.
    Fiebrich F; Koch H
    Experientia; 1979 Dec; 35(12):1548-60. PubMed ID: 118048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of long-term exposure to environmental levels of polychlorinated biphenyls on pharmacokinetics of pentobarbital in rats.
    Chu CK; Stella VJ; Bruckner JV; Jiang WD
    J Pharm Sci; 1977 Feb; 66(2):238-41. PubMed ID: 402468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physiologic and pharmacologic aspects of barbiturates in elasmobranchs.
    Walker MD
    Comp Biochem Physiol A Comp Physiol; 1972 May; 42(1):213-21. PubMed ID: 4402710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.